Time-Restricted Eating: Evidence and Limits

Does when you eat matter independently of how much you eat? That is the only question separating time-restricted eating from ordinary calorie restriction, and randomized trials have been built to answer it. The results are less flattering to the timing hypothesis than the mechanism story suggests.

What happens when the window is the only variable

The TREAT trial (Lowe et al., JAMA Internal Medicine, 2020) randomized 116 adults with overweight or obesity to eat only between noon and 8pm, or to eat three structured meals across a conventional day, with no calorie target for either group. Over 12 weeks the time-restricted group lost 0.94 kg (95% CI, −1.68 to −0.20; P = .01) and the control group 0.68 kg (95% CI, −1.41 to 0.05; P = .07). The difference between them was −0.26 kg (95% CI, −1.30 to 0.78; P = .63) — not significant, and too small to matter clinically.

The body-composition result from TREAT’s 50-participant in-person cohort was more surprising. Whole-body fat mass did not change significantly in the time-restricted group (−0.51 kg; 95% CI, −1.17 to 0.15; P = .13), but appendicular lean mass index fell significantly and by more than in controls (between-group difference −0.16 kg/m²; 95% CI, −0.27 to −0.05; P = .005). Of the 1.70 kg lost in that group, roughly 1.10 kg — about 65% — was lean mass, which the authors noted far exceeds the usual 20% to 30%.

Across the randomized trials that hold calories constant, the eating window itself adds little. In TREAT it added nothing measurable to weight loss while costing lean mass; in the 12-month TREATY trial it was not superior to calorie restriction alone.

The longer, calorie-matched test

TREATY (Liu et al., New England Journal of Medicine, 2022) ran the cleaner comparison for a year: 139 adults with obesity in China assigned to an 8am–4pm window plus calorie restriction, or the same calorie restriction with no timing rule (1500–1800 kcal/day for men, 1200–1500 for women). At 12 months the time-restricted group had lost 8.0 kg (95% CI, −9.6 to −6.4) and the calorie-restriction group 6.3 kg (95% CI, −7.8 to −4.7). The net difference — −1.8 kg (95% CI, −4.0 to 0.4; P = 0.11) — was not significant.

Trial	Population	Comparison	Result
TREAT, 12 weeks	116 adults, overweight/obesity	16:8 window vs 3 structured meals	−0.26 kg between groups (95% CI, −1.30 to 0.78; P = .63)
TREATY, 12 months	139 adults with obesity	8-h window + calorie restriction vs calorie restriction	−1.8 kg net (95% CI, −4.0 to 0.4; P = 0.11)
Pavlou et al., 6 months	75 adults with type 2 diabetes	8-h window vs calorie restriction vs control	HbA1c fell −0.91% (TRE) and −0.94% (CR) vs control; no difference between them
Sun et al. meta-analysis	8 RCTs, 579 participants	TRE + calorie restriction vs calorie restriction	−1.40 kg (95% CI, −1.81 to −1.00); no benefit on blood pressure, glucose or lipids

What the pooled data adds

A 2023 systematic review and meta-analysis in the European Journal of Clinical Nutrition pooled eight randomized trials (579 participants). Adding a restricted window to calorie restriction produced a small extra weight reduction — weighted mean difference −1.40 kg (95% CI, −1.81 to −1.00) — plus reductions in fat mass and waist circumference, but no significant advantage for blood pressure, glucose profile, or lipid profile. A small edge on the scale; nothing on the risk factors.

A 6-month trial in 75 adults with type 2 diabetes (Pavlou et al., JAMA Network Open, 2023) makes the same point on glycemia: HbA1c fell −0.91% with an 8-hour window and −0.94% with calorie restriction relative to control, with no difference between the two strategies.

The longevity gap

No human trial has tested whether time-restricted eating extends lifespan or healthspan. Every trial above measured weight, body composition, or metabolic markers over 12 weeks to 12 months. The longevity case rests on rodent time-restricted feeding and mechanism, not human outcomes.

The takeaway

Time-restricted eating is a workable adherence tool: closing the kitchen at 8pm is an easier rule for some people than counting. What the randomized evidence does not support is that timing does something calories do not. TREAT found no weight advantage and a significant lean-mass cost; TREATY found no advantage at 12 months; pooled data show a ~1.4 kg edge with no cardiometabolic benefit. If the window helps you eat less, it helps — but nothing in the human data makes it a longevity intervention. Related: fasting and longevity and 16:8 vs OMAD.

Sources

• TREAT randomized clinical trial (Lowe et al., JAMA Internal Medicine, 2020)
• Time-restricted eating on weight loss: implications from the TREATY study (Life Medicine, 2022)
• Time-restricted eating with calorie restriction on weight loss and cardiometabolic risk: systematic review and meta-analysis (European Journal of Clinical Nutrition, 2023)
• Time-restricted eating and weight loss in adults with type 2 diabetes (Pavlou et al., JAMA Network Open, 2023)